Navigation Links
Direct-to-consumer genetic testing -- 2-day symposium
Date:8/26/2009

Companies are increasingly offering genetic tests directly to consumers to assess their risk for illnesses such as breast cancer or diabetes. These tests have raised concerns over whether people will receive adequate counseling -- given that the tests are not administered by health care providers -- and whether consumers' genetic information will be kept private, among other issues.

On Aug. 31 and Sept. 1 the National Research Council and Institute of Medicine will hold a symposium to explore the health, policy, and ethical implications of direct-to-consumer genetic testing.

SYMPOSIUM DETAILS: 8 a.m. to 5 p.m. on Aug. 31 and from 9 a.m. to 2:30 p.m. on Sept. 1 in Room 100 of the National Academies' Keck Center, 500 Fifth St., N.W., Washington, D.C. A preliminary agenda is available at http://sites.nationalacademies.org/PGA/stl/PGA_050739.

AUDIO WEBCAST: Morning sessions on Aug. 31 -- covering the history and likely evolution of direct-to-consumer genetic testing, as well as the regulatory framework -- will be available via live audio webcast at http://national-academies.org.


'/>"/>

Contact: Sara Frueh
news@nas.edu
202-334-2138
National Academy of Sciences
Source:Eurekalert

Page: 1

Related biology news :

1. Direct-to-consumer advertising for genetic tests concerns physicians and may mislead patients
2. Scientists link genetic glitches to common childhood cancer
3. Researchers find genetic link between physical pain and social rejection
4. Scientists take early steps toward mapping epigenetic variability
5. USC researchers identify regulatory genetic sequences that may predict risk for prostate cancer
6. Carnegie Mellon develops innovative method to detect genetic causes of complex diseases
7. New study suggests possible genetic links between environmental toxins and multiple myeloma
8. Discovery of genetic mutation in Leigh syndrome
9. Joint research into an enzyme that causes genetic diseases
10. First genetically-engineered malaria vaccine to enter human trials
11. Comprehensive look at rare leukemia finds relatively few genetic changes launch disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... --  Strategic Cyber Ventures , the industry,s first cybersecurity ... million investment in  Polarity , the first commercial human ... based and is led by cybersecurity veterans Tom ... Gula , also a longtime cybersecurity veteran and founder ... A round of funding. This new funding will be ...
(Date:2/24/2017)... , Feb. 24, 2017  EyeLock LLC, a leader of ... elite iris biometric solution on the latest Qualcomm® ... at Mobile World Congress 2017 (February 27 ... in Hall 3, Stand 3E10. ... Haven™ security platform—a combination of hardware, software ...
(Date:2/21/2017)... N.Y. and PORTLAND, Ore. ... ) and the Avamere Family of Companies (Avamere Health ... today announced a six-month research study that will apply ... improve eldercare at senior living and health centers. By ... Avamere hopes to gain insights into physical and environmental ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... March 23, 2017 , ... Ellen Matloff, president and ... Council (CTC) as a 2017 Women of Innovation® finalist. Matloff will be among ... Dinner. , The dinner recognizes women accomplished in science, technology, engineering and math ...
(Date:3/23/2017)... According to a report by Transparency Market ... due to the presence of a large pool of participants; however, ... , and Sigma-Aldrich, compete with each other in this market. With ... than 76% of this market in 2016.  ... As of now, a large number of ...
(Date:3/23/2017)... Orleans, La. (PRWEB) , ... March 23, 2017 ... ... real-time, industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd ... APMT customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career ...
(Date:3/22/2017)... , March 22, 2017  Ascendis Pharma ... its innovative TransCon technology to address significant unmet ... results for the full year ended December 31, ... year for our company as we broadened our ... leading, integrated rare disease company with an initial ...
Breaking Biology Technology: